期刊文献+

肺炎克雷伯菌的喹诺酮类耐药株gyrA基因研究

Study on GyrA gene of quinolone-resistant Klebsiella pneumoniae strains
在线阅读 下载PDF
导出
摘要 目的分析肺炎克雷伯菌的喹诺酮类耐药株gyrA基因的耐药机制。方法收集经Phoenix 100全自动细菌鉴定系统鉴定分离的肺炎克雷伯菌的喹诺酮类耐药株43株,采用聚合酶链反应(PCR)方法进行gyrA基因检测,扩增产物纯化后测序并进行序列分析。结果43株肺炎克雷伯菌的喹诺酮类耐药株均发生gyrA基因突变,gyrA基因的PCR扩增均得到目的片段,扩增产物长度为441 bp。结论肺炎克雷伯菌的喹诺酮类耐药株gyrA基因突变非常普遍,监测其突变频率及特点对研究喹诺酮类耐药机制和指导临床合理用药非常必要。 Objective To analyze the drug resistance mechanism of GyrA gene of quinolone-resistant Klebsiella pneumoniae strains. Methods 43 quinolone-resistant Klebsiella pneumoniae strains identified and isolated by Phoenix 100 system were collected and detected by polymerase chain reaction(PCR) for GyrA gene,and the amplified products were purified and sequenced for sequence analysis. Results All 43 quinoloneresistant Klebsiella pneumoniae strains were found to have GyrA gene mutation. PCR amplification of the GyrA gene yielded the target fragment, and the length of the amplified product was 441 bp. Conclusion GyrA gene of quinolone-resistant Klebsiella pneumoniae strains is very common. Monitoring the mutation frequency and characteristics is very important for the study of the drug resistance mechanism of quinolone and the guidance of clinical rational drug use.
作者 郭丽娜 王家欣 姚文 刘琦琦 GUO Li-na;WANG Jia-xin;YAO Wen(Baotou Medical College Second Affiliated Hospital,Baotou 014030,China)
出处 《中国实用医药》 2023年第1期173-175,共3页 China Practical Medicine
基金 包头医学院科学研究基金项目-青苗计划(项目编号:BYJJ-QM-2018023) 内蒙古自治区高等学校科学研究项目(项目编号:NJZC17246)。
关键词 肺炎克雷伯菌 喹诺酮类 耐药机制 基因突变 Klebsiella pneumoniae Quinolone Drug resistance mechanism Genetic mutations
  • 相关文献

参考文献10

二级参考文献104

  • 1王琴,姚智,杨萍,胡静仪,郭海峰,张立,宋琳娜.产超广谱β-内酰胺酶和质粒介导的AmpC酶肺炎克雷伯菌耐药性及基因型研究[J].中华医院感染学杂志,2005,15(3):256-260. 被引量:47
  • 2王志锐,李力,张坚磊,陈锦艳,苏旭,丁建清.耐药铜绿假单胞菌携带的整合子及其耐药基因盒检测分析[J].中华检验医学杂志,2007,30(7):802-803. 被引量:12
  • 3杨霞,王川庆,卢中华.细菌耐药性的分子机制研究进展[J].河南农业大学学报,2007,41(3):350-355. 被引量:3
  • 4Fu Y, Guo L,Xu Y,et al. Alteration of GyrA amino acid required for ciprofloxacin resistance in Klebsiella pneumoniae i solates in china[J]. Antimicrob Agents Chemother, 2008,52 (8) 2980- 2983.
  • 5Feizahadi MM,Delfani S,Raji N,et al. Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneurnoniae at Labbafinejad hospital, Tehran, Iran[J]. Microb Drug Resist, 2010,16 (1) : 49- 53.
  • 6Gruteke P,Goessens W,Van Gils J,et al. Patterns of resistance associated with integrons, the extended-spectrum betalactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak[J]. J Clin Microbiol, 2003,41 (3) : 1161-1166.
  • 7Chen FJ,Lauderdale TL, Ho M,et al. The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae [ J ]. Mierob Drug Resist, 2003,9 (3) : 265-271.
  • 8HrabakJ, Empel J, Bergerova.T, et al. International clones of Klebsiella pneumoniae and Escherichia coli with extended- spectrum β-lactamases in a Czech hospital[J].J Clin Microbiol,2009,47(10) :3353-3357.
  • 9Alovero FL,Pan X,Morris JE,et al.Engineering the specificity of fluoroquinolones:Benzenesulfonamide modification at C-7 of ciprofloxacin change its target in Streptococcus pneumoniae [J].Antimicorb Agents Chemother ,2000,44 (13):320
  • 10Craig WA,Andes DR.Correlation of the magnitude of the AUC24/MIC for 6 fluoroquinolones against Streptococcus pneumoniae with survival and bactericidal activity in an animal model [C].Canada:Program & Abstracts of 40th ICAAC,2000,17

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部